PsA ℞: IL17 Inhibitors - Arthritis Rheumatism

Subcutaneous Secukinumab Relieves Psoriatic Arthritis

The interleukin-17A inhibitor is effective and safe, according to first results…

medscape.com

Cosentyx Gets Radiographic Protection Indication for Psoriatic Arthritis

Novartis announced today that the US Food and…

rheumnow.com

PsA Structural Damage Inhibited with Secukinumab

medpagetoday.com

Ixekizumab (Taltz) FDA Approved for Psoriatic Arthritis

rheumnow.com

Lilly’s Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod

fiercepharma.com

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

ard.bmj.com

Translate »